Physician

Adriana Lombardi, M.D.

According to 2025 Medicare claims, Adriana Lombardi, M.D. (NPI: 1689938805) practices dermatology in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Middlesex, NJ. This provider's primary affiliated billing organization is SKIN CANCER AND COSMETIC SURGERY CENTER OF NEW JERSEY, LLC (NPI: 1770067126; TIN: 831263322) and primary practice location at 08837-2429.

Lombardi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 345 traditional Medicare patients, billed 2,661 HCPCS/CPT codes, and received $340,900 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 591 prescription claims across 262 beneficiaries totaling $69,561 in drug costs, led by Otezla (Apremilast). Open Payments data shows 98 records totaling $1,751. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $57,336 and ending at $340,900. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $12,151 to $69,561. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$217K$433K2015 Medicare payment: $57,336 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $320,945 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $339,896 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $433,205 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $134,642 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $55,917 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $142,253 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $196,543 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $218,660 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $340,900 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015306941$57,336
20165891,965$320,945
20175952,675$339,896
20186643,541$433,205
20193561,829$134,642
2020113741$55,917
20212131,447$142,253
20222972,195$196,543
20232852,191$218,660
20243452,661$340,900

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$35K$70K2015 Drug cost: $12,151 (USD; Tot_Drug_Cst)2016 Drug cost: $10,062 (USD; Tot_Drug_Cst)2017 Drug cost: $11,143 (USD; Tot_Drug_Cst)2018 Drug cost: $12,322 (USD; Tot_Drug_Cst)2019 Drug cost: $16,814 (USD; Tot_Drug_Cst)2020 Drug cost: $28,940 (USD; Tot_Drug_Cst)2021 Drug cost: $12,956 (USD; Tot_Drug_Cst)2022 Drug cost: $32,078 (USD; Tot_Drug_Cst)2023 Drug cost: $29,915 (USD; Tot_Drug_Cst)2024 Drug cost: $69,561 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201595169$12,151
2016211339$10,062
2017249453$11,143
2018327615$12,322
2019186387$16,814
202099210$28,940
2021186381$12,956
2022213463$32,078
2023209427$29,915
2024262591$69,561

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths105146$95
11102Biopsy of related skin growth, first growth138172$76
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more278522$69
17000Destruction of precancer skin growth, 1 growth152227$42
17003Destruction of precancer skin growth, 2-14 growths114760$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OtezlaApremilast11330$49,733
FluorouracilFluorouracil601,835$3,778
Clobetasol PropionateClobetasol Propionate381,011$1,586
MupirocinMupirocin2092,639$1,385
CiclopiroxCiclopirox Olamine591,730$1,030

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.98$1,751ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adriana Lombardi, M.D.?

Tedicare shows public-source Medicare data for Adriana Lombardi, M.D. (NPI 1689938805), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adriana Lombardi, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adriana Lombardi, M.D.?

Adriana Lombardi, M.D. is linked to SKIN CANCER AND COSMETIC SURGERY CENTER OF NEW JERSEY, LLC (billing NPI 1770067126) in the available physician profile data.

Does Adriana Lombardi, M.D. have Open Payments data?

Adriana Lombardi, M.D. has 98 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.